Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $749,762 - $854,319
-13,235 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$62.1 - $78.08 $329,130 - $413,824
-5,300 Reduced 28.59%
13,235 $836,000
Q2 2020

Aug 10, 2020

SELL
$72.34 - $84.0 $2.3 Million - $2.67 Million
-31,791 Reduced 63.17%
18,535 $1.43 Million
Q1 2020

May 05, 2020

SELL
$62.63 - $80.22 $15.1 Million - $19.3 Million
-240,385 Reduced 82.69%
50,326 $3.76 Million
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $3.3 Million - $3.63 Million
-53,507 Reduced 15.54%
290,711 $18.9 Million
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $1.3 Million - $1.43 Million
-20,772 Reduced 5.69%
344,218 $21.8 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $279,714 - $313,666
-4,521 Reduced 1.22%
364,990 $24.7 Million
Q1 2019

May 02, 2019

SELL
$62.53 - $70.05 $146,257 - $163,846
-2,339 Reduced 0.63%
369,511 $24 Million
Q4 2018

Feb 04, 2019

SELL
$60.54 - $79.0 $1.86 Million - $2.42 Million
-30,642 Reduced 7.61%
371,850 $23.3 Million
Q3 2018

Oct 29, 2018

BUY
$71.28 - $78.92 $490,121 - $542,653
6,876 Added 1.74%
402,492 $31.1 Million
Q2 2018

Jul 25, 2018

BUY
$64.88 - $75.68 $786,670 - $917,620
12,125 Added 3.16%
395,616 $0
Q1 2018

Apr 25, 2018

BUY
$72.84 - $88.8 $1.51 Million - $1.84 Million
20,703 Added 5.71%
383,491 $0
Q4 2017

Feb 02, 2018

SELL
$71.15 - $83.52 $1.34 Million - $1.57 Million
-18,765 Reduced 4.92%
362,788 $0
Q3 2017

Oct 27, 2017

BUY
$72.11 - $85.47 $27.5 Million - $32.6 Million
381,553
381,553 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.